NCT03592290 Hemodynamics Monitoring During Lower Body Negative Pressure (LBNP) Induced Controlled Hypovolemia
| NCT ID | NCT03592290 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Hypovolemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2017-11-15 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2017-11-15 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To monitor the changes in central and peripheral monitors/waveforms during gradual hypovolemia induced by lower body negative pressure in healthy volunteers.
Eligibility Criteria
Inclusion Criteria: \* Healthy volunteers aged 20-45 with Exclusion Criteria: * Pregnant women * Under 20 years of age * Subjects with coronary artery disease, diabetes, epilepsy and hypertension
Contact & Investigator
Aymen Alian, MD
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT03592290 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 45 Years, studying Hypovolemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03592290 currently recruiting?
Yes, NCT03592290 is actively recruiting participants. Contact the research team at aymen.alian@yale.edu for enrollment information.
Where is the NCT03592290 trial being conducted?
This trial is being conducted at New Haven, United States.
Who is sponsoring the NCT03592290 clinical trial?
NCT03592290 is sponsored by Yale University. The principal investigator is Aymen Alian, MD at Yale University. The trial plans to enroll 120 participants.